Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram (citalopram hydrobromide) from Aurobindo Pharma Limited.
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for the generic antidepressant citalopram, authorizing Chartwell Governmental & Specialty RX, LLC to…
-
FDA approval · 2008-06-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited as an original application for a generic antidepressant product…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (BluePoint Laboratories)
FDA approved an original application for venlafaxine from BluePoint Laboratories (venlafaxine hydrochloride) under an Abbreviated New Drug A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic venlafaxine under an original ANDA (ANDA078627). The approval adds a generic option for treating m…
-
FDA approval · 2008-06-03FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for mirtazapine from Sun Pharmaceutical Industries, indicating regulatory clearance related to a gen…
-
FDA approval · 2008-05-29FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. under anANDA, confirming r…
-
FDA approval · 2008-05-23FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-21FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
FDA approval · 2008-05-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Vertical Pharmaceuticals, LLC)
The FDA approved a generic venlafaxine hydrochloride product (Original Application) developed by Vertical Pharmaceuticals, LLC, for the trea…
-
FDA approval · 2008-04-23FDA Approved: APLENZIN — Original Application (Bausch Health US, LLC)
FDA approved APLENZIN (bupropion hydrobromide) through an original application for the treatment of major depressive disorder.
-
FDA approval · 2008-04-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine by Teva Pharmaceuticals USA, Inc. The approval updates the product labeling and/o…
-
FDA approval · 2008-04-14FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, indicating regulatory clearance for a…
-
FDA approval · 2008-04-14FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Amoxapine by Actavis Pharma, Inc. The submission status indicates approval (AP).
-
FDA approval · 2008-04-03FDA Approved: CITALOPRAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Citalopram from Amneal Pharmaceuticals LLC.
-
FDA approval · 2008-03-21FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.
-
FDA approval · 2008-03-09FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-06FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Mylan Pharmaceuticals Inc., indicating approval of a supplemen…
-
FDA approval · 2008-02-29FDA Approved: PRISTIQ EXTENDED-RELEASE — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved Pristiq Extended-Release (desvenlafaxine succinate) as an original NDA for the treatment of major depressive disorder; Wyeth Ph…
-
FDA approval · 2008-02-20FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for imipramine hydrochloride (generic) from Strides Pharma Science Limited, authorizing a modifi…
-
FDA approval · 2008-02-20FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited. This is a supplemental approval fo…
-
FDA approval · 2008-02-14FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine from Chartwell Governmental & Specialty RX, LLC.